Brief: RepliCel Life Sciences And Yofoto (China) Health Obtain Approvals Needed To Complete Investment
24/09/2018 11:46
Sept 24 (Reuters) - RepliCel Life Sciences Inc RP.V :
* REPLICEL LIFE SCIENCES AND YOFOTO (CHINA) HEALTH OBTAIN
ALL
APPROVALS NEEDED TO COMPLETE INVESTMENT
* REPLICEL LIFE SCIENCES - YOFOTO (CHINA) HEALTH, CO NOW
CLEARED
TO CLOSE INVESTMENT TRANSACTION AND COMMENCE COLLABORATION
ACTIVITY IN GREATER CHINA
Source text for Eikon: ID:nPn1MVT3va
Further company coverage: RP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector